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Abstract 
Background: The tumor microenvironment and its stromal cells play an important role in cancer 
development and metastasis. Bone marrow-derived cells (BMDCs), a rich source of hematopoietic and 
mesenchymal stem cells, putatively contribute to this tumoral stroma. However their characteristics and 
roles within the tumor microenvironment are unclear. In the present study, BMDCs in the tumor 
microenvironment were traced using the green fluorescent protein (GFP) bone marrow transplantation 
model.  
Methods: C57BL/6 mice were irradiated and rescued by bone marrow transplantation from 
GFP-transgenic mice. Lewis lung cancer cells were inoculated into the mice to generate subcutaneous 
allograft tumors or lung metastases. Confocal microscopy, immunohistochemistry for GFP, α-SMA, 
CD11b, CD31, CD34 and CD105, and double-fluorescent immunohistochemistry for GFP-CD11b, 
GFP-CD105 and GFP-CD31 were performed. 
Results: Round and dendritic-shaped GFP-positive mononuclear cells constituted a significant stromal 
subpopulation in primary tumor peripheral area (PA) and metastatic tumor area (MA) 
microenvironment, thus implicating an invasive and metastatic role for these cells. CD11b co-expression 
in GFP-positive cells suggests that round/dendritic cell subpopulations are possibly BM-derived 
macrophages. Identification of GFP-positive mononuclear infiltrates co-expressing CD31 suggests that 
these cells might be BM-derived angioblasts, whereas their non-reactivity for CD34, CD105 and α-SMA 
implies an altered vascular phenotype distinct from endothelial cells. Significant upregulation of 
GFP-positive, CD31-positive and GFP/CD31 double-positive cell densities positively correlated with PA 
and MA (P<0.05). 
Conclusion: Taken together, in vivo evidence of traceable GFP-positive BMDCs in primary and 
metastatic tumor microenvironment suggests that recruited BMDCs might partake in cancer invasion and 
metastasis, possess multilineage potency and promote angiogenesis. 
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Introduction 
The tumor microenvironment plays a pivotal 
role in cancer development and progression [1]. 
Unlike its naive counterpart which maintains 
physiological homeostasis of normal tissues, the 
tumor microenvironment is a pathologically active 
niche that contributes to tumor growth and metastasis 
by collaborating with tumor cells [2,3]. Within this 
tumoral stroma, many structurally and functionally 
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essential stromal elements including cancer- 
associated fibroblasts (CAFs) and myofibroblasts 
participate in the regulation of solid tumor 
progression [4-7]. In addition other tumor-associated 
stromal cells namely macrophages, endothelial cells 
and T cells contribute to tumor invasion and 
metastasis [8-10]. 
Bone marrow is a complex tissue comprising a 
heterogeneous population of multipotent cells 
including hematopoietic and mesenchymal stem cells. 
These bone marrow-derived cells (BMDCs) have been 
frequently investigated as a cell source for 
regenerative medicine application [11]. In cancers, 
thus far it is known that circulating BMDCs switched 
their phenotypes to hepatocytes [11], endothelial cells 
[12,13], myofibroblasts [14] and gastrointestinal 
epithelial cells in vivo [15-17]. Furthermore, in gastric 
cancer, the stromal cells including CAFs were 
reported to originate from BMDC [18].  
Although the multilineage differentiation 
capacity of BMDC has been explored [11-18], the 
distribution, differentiation characteristics and roles 
of BMDCs in cancer development and metastasis 
remain unclear. To investigate how BMDCs influence 
tumor invasion and metastasis, a mouse bone marrow 
transplantation model was created by grafting bone 
marrow from green fluorescent protein (GFP) mice 
into isogenic wild-type mice. These mice were 
transplanted with Lewis lung cancer (LLC) cells 
injected subcutaneously into their back or tail vein. 
This mouse model allowed tracking of BMDC by 
tracing for GFP-positive cells. The location of 
GFP-positive cells in tumor tissues, and GFP-positive 
cell differentiation were also determined. 
Material and Methods 
Experimental animals 
A total of 23 female mice was used. These 
consisted of eight GFP transgenic mice (C57BL/6-Tg 
[CAG- EGFP] OsbC14-Y01-FM131) (gift from 
Professor Masaru Okabe, Genome Information 
Research Center, Osaka University, Suita, Japan) and 
15 C57BL/6 mice purchased from Okayama 
University Animal Center.  
All experimental protocols complied with the 
guidelines of the Okayama University Care and Use 
of Laboratory Animals. This research was approved 
by the Animal Experiment Control Committee of the 
Okayama University Graduate School of Medicine, 
Dentistry and Pharmaceutical Sciences (05-006-099). 
Bone marrow transplantation 
Bone marrow transplantation was carried out 
according to a standard protocol as described 
previously [19]. Bone marrow cells from GFP mice 
were collected by introducing DMEM (Invitrogen, 
Grand Island, NY) into the marrow space. Cells were 
resuspended with HBSS into approximately 1.0 × 107 
cells/0.2 ml. Meanwhile, 8-week old female C57BL/6 
recipient mice were subjected to 10 Gy of lethal 
whole-body irradiation, and resuspended bone 
marrow cells were injected into the tail vein of 
recipient mice. The bone marrow was examined by 
GFP immunohistochemistry (IHC) 4 weeks after 
transplantation. 
Tumor cell culture 
LLC cells purchased from American Type 
Culture Collection (ATCC Manassas,VA, USA) were 
maintained in DMEM supplemented with 10% FBS, 
100 U/ml antimyotic-antibiotic 100 mg/ml at 37 °C in 
a humidified atmosphere at 5% CO2. 
Tumor transplantation 
12-week-old C57BL/6J female mice that received 
GFP bone marrow transplantation were injected 
subcutaneously into the back with 1.0 × 106 LLC cells 
(n = 5) or injected into the tail vein with 5.0 × 105 LLC 
cells (n = 5). We defined the former as primary model, 
and the latter as metastatic model. The bone marrow 
transplantation mouse was defined as control. At 28 
days, all mice were sacrificed and the specimens were 
harvested for analysis. 
Histological examination 
All excised tumor tissues were fixed in 4% 
paraformaldehyde for 12 h. Tissues were processed 
routinely, embedded in paraffin wax, and 5 
micron-thick serial sections were prepared. These 
sections were used for hematoxylin-eosin (HE) 
staining, IHC and double fluorescent IHC.  
Immunohistochemistry 
IHC was carried out using the antibodies 
detailed in Table 1. Following antigen retrieval, 
sections were treated with 10 % normal serum for 30 
min, and then doing incubation with primary 
antibodies at 4°C overnight. The immunoreactive site 
was identified using the avidin–biotin complex 
method (Vector Lab, Burlingame, CA, USA). 
Double-fluorescent IHC staining 
Double-fluorescent IHC for GFP-CD11b, 
GFP-CD105, and GFP-CD31 was performed using 
GFP monoclonal antibody (Abcam, Tokyo, Japan). 
The secondary antibodies used are detailed in Table 2. 
Antibodies were diluted with Can Get SignalÒ 
(TOYOBO, Osaka, Japan). After antigen retrieval, 
sections were treated with Block AceÒ (DS Pharma 
Bio-medical, Osaka, Japan) for 30 min at room 
temperature. Specimens were incubated with primary 
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antibodies at 4 °C overnight. These specimens were 
then incubated with secondary antibody at a dilution 
of 1:200 for 1 h at room temperature. After the 
reaction, the specimens were stained with 1 lg/ml of 
DAPI (Dojindo Laboratories, Kumamoto, Japan).  
Cell counting 
Cell counting was performed according to three 
areas (Fig. 1A) of division: 1) peripheral area (PA) 
(Fig. 1C) of primary tumor model (tumoral tissue 
interacted with peripheral stroma); 2) central area 
(CA) (Fig. 1D) of primary tumor model (tumoral 
tissue away from peripheral stroma); and 3) 
metastatic area (MA) (Fig. 1E) of metastatic tumor 
model (tumoral tissue metastasized in lung). The 
subsequent histological analysis and characterization 
of LLC cells and BMDC were made based on this area 
division. 
After counterstaining with hematoxylin, sections 
were examined under a microscope at 400 
magnification. Ten areas were randomly chosen in 
each sample. The number of positively labelled cells 
was counted manually, the average was obtained and 
compared among the 3 groups.  
Vessel density 
IHC was performed using antibody against 
mouse CD105, and the density of tumor vessels was 
scored by BZ-X700 all in one microscope (Keyence, 
Osaka, Japan). 
Statistical analyses 
The statistical data was presented as the mean 
±SEM. The comparisons between the mean variables 
of the two groups were performed using Student’s t 
test. The difference was considered significant at 
P<0.05. 
 
Table 1. Antibodies used in immunohistochemistry 
 
 
Table 2. Antibodies used in double-fluorescent immunohistochemistry 
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Results 
Morphological characterization of primary and 
metastatic models 
Solid LLC tumors grew in both primary and 
metastatic models (Fig. 1A, 1B). The primary tumors 
consisted of a peripheral area of loosely arranged 
spindle-shaped tumor cells which were in contact 
with stromal cells (Fig. 1C). In the central tumor area, 
these tumor cells formed a compact pleomorphic 
population of large, round-to-polygonal cells with 
nuclear atypia. These cells were not in contact with 
stromal cells (Fig. 1D).  
In the metastatic model, the tumors presented as 
multifocal nodular masses (Fig. 1B). Each metastatic 
nodule consisted of a central area of compact 
round-to-polygonal tumor cells (not shown), and 
peripheral loosely-arranged spindle-shaped cells, the 
latter of which were in close contact with the stromal 
cellular components (Fig. 1E).  
 
 
Figure 1. Histopathological appearances and IHC of GFP. (A-E) Hematoxylin-eosin (HE) staining. Loupe image of (A) primary model and (B) metastasis model. (C) 
peripheral area (PA). Spindle tumor cells are observed and infiltrate to peripheral tissue. (D) central area (CA). Round or angulated tumor cells are observed. (E) metastasis area 
(MA). (F-H) GFP immunohistochemical staining (IHC). GFP positive cells are mononuclear cells and round or dendritic cells. (F) PA, (G) CA, (H) MA. (I) The number of GFP 
positive cells are significantly higher in PA and MA than CA (p < 0.05). In MA, GFP positive cells infiltrate tumor diffuse, and cell density is similar PA. Bars: AB, 500 μm; C-H, 20 
μm. 
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Figure 2. IHC features of α-SMA and CD11b. (A-C) α-SMA. (A) PA, (B) CA, (C) MA. (D-F) CD11b. Round shape CD11b positive cells observed. (D) PA, (E) CA, (F) MA. 
(G) The number of CD11b positive cells are significantly higher in PA than CA (p < 0.05). (H-J) Immunofluorescence double stain with CD11b and GFP. (H) CD11b, (I) GFP, (J) 
merge image of CD11b and GFP. Bars: A-F and H-J, 20 μm. 
 
IHC localization of GFP-positive cells 
Abundant GFP-positive cells infiltrated the 
tumor microenvironment of both models. These 
GFP-positive cells presented as round or dendritic 
mononuclear cells (Fig. 1F-H).  
Expression of various markers by tumor 
stromal cells and comparison with GFP- 
positive cells  
α-SMA labelled smooth muscle of stromal blood 
vessels in both primary and metastatic models. No 
difference in α-SMA distribution in CA, PA and MA 
was observed. GFP-positive round or dendritic cells 
were negative for α-SMA (Fig. 2A-C). A small number 
of spindle-shaped cells that did not form α-SMA 
positive lumen was observed in PA (Fig. 2A). 
Abundant CD11b-positive cells infiltrated the 
tumoral stroma of both primary and metastatic 
models. These cells were spherical or dendritic in 
shape, morphologically similar to GFP-positive cells 
(Fig. 2D-F). Numerous of these spherical 
CD11b-positive cells were also observed in necrotic 
tumor areas in CA. 
CD31, CD34 and CD105 were positive for 
vascular endothelial cells of blood vessels in the 
tumor tissue (Figs. 3A-F, 4A-C). These vessels have 
central lumens or slit-like spaces. In addition, most of 
these vessels in PA and MA have smaller lumens 
whereas numerous mature blood vessels with large 
lumens were observed in CA (Figs. 3A-F, 4A-C). 
Spherical or dendritic stromal cells were positive for 
CD31 but were nonreactive for CD34 and CD105 (Fig. 
4A-C). These cells morphologically resembled 
GFP-positive cells. 
Analysis of double-fluorescent IHC staining 
CD 11 b and GFP 
Spherical GFP-positive cells co-expressing 
CD11b were observed in both tumor models. These 
double positive cells infiltrated necrotic tumor sites of 
CA (Fig. 2H-J) and to a lesser extent those of PA and 
MA.  
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CD 105 and GFP 
In all sites examined for both primary tumor and 
metastatic lesion, double positive CD105 and GFP 
endothelial cells were not observed (Fig. 3G-I). 
CD31 and CD 105 
Both CD31 and CD105 were positive in vascular 
endothelial cells showing lumen formation (Fig. 4G 
arrow). In addition CD31 was positive in spherical or 
dendritic cells with no evidence of lumen formation 
(Fig. 4G arrowhead). 
CD31 and GFP 
In PA and MA, spherical cells double positive for 
CD31 and GFP were observed (Fig. 4H-J). 
Cell counting analysis of IHC positive cells 
Results of cell-counting based on IHC staining 
for GFP, CD11b, CD31 and double fluorescent IHC for 
GFP-CD31 according to the three area divisions PA, 
CA and MA are shown in the histograms (Figs. 1I, 2G, 
4D and 4K). PA and MA consistently showed 
significantly higher scores for GFP-positive cells (Fig. 
1I), CD31-positive cells (Fig. 4D) and CD31/GFP 
double positive cells than CA (Fig. 4K) (P<0.05). Only 
CD11b-positive cells scored highest in CA. 
Measurement of blood vessel area 
Data based on measurement of blood vessel area 
in CA, PA and MA are shown in Fig 3J. Both PA and 
MA showed significantly higher blood vessel area 
than CA. (Fig. 3J). 
 
 
Figure 3. IHC features of CD34 and CD105. (A-C) CD34. (A) PA, (B) CA, (C) MA. (D-F) CD105. (D) PA, (E) CA, (F) MA. Positive staining of CD34 and CD105 shown in 
only vascular endothelial cells. (G-H) Immunofluorescence double stain with GFP and CD105. (G) GFP, (H) CD105, (C) merge image of CD105 and GFP. Endothelial cells (green) 
are negative for GFP (red). (J) PA and MA vascular density is significant higher than CA (p < 0.05). Bars: A-I, 20 μm. 
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Figure 4. IHC features of CD31. (A-C) CD31. (A) PA, (B) CA, (C) MA. (D) The number of CD31 positive round or dendritic cells are significantly higher in PA and MA than 
CA (p < 0.05). (H-J) Immunofluorescence double stain with CD31 and GFP. (H-J) merge image of CD31 and GFP. Double positive mononuclear cells are mainly observed in PA 
and MA (arrow head), but few numbers in CA. (K) The number of CD31/GFP double positive cells are significantly higher in PA and MA than CA (p < 0.05). Bars: A-C and E-J, 
20 μm. 
 
Discussion 
The heterogeneity of the stromal cellular 
populations within the tumor microenvironment 
makes definitive characterization inherently 
challenging [3,4,6]. Tracing BMDCs and their 
differentiated phenotypes in the neoplastic cell 
extrinsic environment formed our main research goal. 
The GFP bone marrow transplantation model offers 
an attractive approach because it enables the tracking 
of BMDCs in both their engraftment and homing sites 
[18,19]. By using this bone marrow transplantation 
model harboring GFP-labeled BMDCs, we 
successfully illustrated here the distribution of the 
various cellular constituents derived from the 
transplanted BMDCs within the primary and 
metastatic tumor microenvironment. We also 
provided morphologic evidence of multilineage 
differentiation by these cells in both tumor sites. Their 
characteristics and potential roles are discussed 
further below.  
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Current data based on GFP positivity suggest 
that a significant population of stromal cells in the 
primary and metastatic tumor microenvironment is 
BM-derived. Abundant GFP-labelled BMDCs have 
been previously described in gastric and colon cancer 
stroma [18,20]. In this study, an invasive role for 
BMDC was demonstrated with evident upregulation 
of GFP-positive cellular infiltrates concentrated in the 
peripheral locations of the primary tumor model. 
Furthermore the close proximity between these 
GFP-positive cellular infiltrates and spindle-shaped 
tumor cells along the peripheral/invasive front was 
interpreted to represent tumor-stromal cell 
interactions. However actual fusion between these cell 
types (multiploidal cells) was not observed [21]. 
Furthermore, a metastatic role for BMDC was 
demonstrated here based on the enhanced presence of 
GFP-positive cellular infiltrates in the lung metastatic 
tumor nodules. Liver metastases of colon cancer were 
also known to show abundant GFP-positive cells [20]. 
Current data further revealed that GFP positivity 
in the primary and metastatic tumoral stroma was 
predominantly monopolized by mononuclear 
infiltrates with round/spherical and dendritic cell 
morphology, thus confirming that these cells are 
BM-derived. Co-expression of CD11b by these 
GFP-positive cells suggests that these 
round/spherical and dendritic cell subpopulations 
are most likely BM-derived mononuclear 
phagocyte/macrophages. CD11b is a known marker 
for monocytes/macrophages and microglia [22]. 
Therefore CD11b/GFP double-positive cells that 
accumulated in the tumor necrotic sites of CA were 
thought to be macrophages that function to 
phagocytize necrotic tissues. On the other hand, 
CD11b-positive cells elsewhere in the tumoral stroma 
were suggested to represent tumor-associated 
macrophages (TAM). TAM is known to be involved in 
tumor growth and metastasis [23], thus suggesting 
that CD11b-positive BMDCs found in tumor tissue 
margins and metastatic lesions may be related to 
TAMs. Recent evidence indicates that BM-derived 
macrophages have an angiogenesis promoting action 
in tumor angiogenesis [24,25]. Therefore, the observed 
significantly higher CD11b-positive BMDCs densities 
within ischemic/necrotic central tumor areas suggest 
that macrophages function to phagocytize foreign 
matter while TAMs are involved in angiogenesis. 
Tumor vessels play a pivotal role in tumor 
development. To clarify the relative contribution of 
BMDCs in the tumoral vasculature of primary and 
metastatic tumor microenvironment, the angiogenic 
index based on IHC using CD31, CD34 and CD105, 
and dual fluorescent IHC using GFP-CD31 and 
GFP-CD105 in both primary and metastatic sites was 
estimated. Current results revealed that endothelial 
cells lining blood vessels in primary and metastatic 
tumoral stroma were not doubly positive for GFP and 
CD105, thus dismissing that these blood vessels are 
BM-derived. Instead GFP-CD31 dual positivity was 
detected in spherical/dendritic cells, implying that 
these might be BM-derived circulating angioblasts. 
BM-derived GFP-positive and CD31-positive cells 
were however not detected in colon cancer allografts 
[20]. These consolidated findings indicate that tumor 
vessels originate mostly from host tissues rather than 
BM-derived circulating angioblasts. Recent evidence 
suggests that endothelial cells may originate from 
either endothelial progenitor cells (EPCs) in the bone 
marrow, angioblasts or vascular stem cells [26-2 8]. A 
favored view is that EPCs are BM-derived on grounds 
that blood cells and endothelial cells are generated 
from the same progenitor cell, and EPCs expressed 
the same antigens, such as CD34, CD31, and Tie-2 as 
hematopoietic precursor cells [29]. These data support 
the notion that not only the existing blood vessels but 
also EPCs in the BM might have been recruited during 
angiogenesis. Moreover, other data indicate that 
BMDCs might differentiate into endothelial cells 
during vascular repair in ischemic lesions including 
myocardial infarction. CD31 positive BMDC support 
angiogenesis strongly, but these cells didn’t different 
to endothelial cells [30- 32]. Tumor-associated 
endothelial cells differ genetically from normal 
vascular endothelium [33]. Whether 
GPF/CD31-positive cells identified here belong to this 
subset of tumor-associated endothelial cells requires 
further investigations [34]. 
An earlier report described that GFP-positive 
cells frequently differentiated into vimentin-positive 
and α–sma-positive myofibroblasts and interstitial 
cells that not only form a capsule but also infiltrated 
the colon cancer allografts [20]. Another study 
propounded that BMDCs might change to 
cancer-associated orthotopic myofibroblasts by the 
education of gastric cells [18]. In contrast to these 
reports, our results disclosed that α-SMA was 
expressed by vascular smooth muscle in the tumor 
tissues, and by spindle-shaped cells considered to be 
myofibroblasts in the peripheral portion of the tumor. 
However, neither of these cell types were 
GFP-positive, thus precluding that they are 
BM-derived stromal affiliates. Moreover, 
GFP-positive round and dendritic cells were negative 
for α-SMA. Based on these findings, we surmised that 
GFP-negative α-SMA-positive spindle cells might 
represent cancer-asssociated fibroblasts (CAFs) 
mobilized from the surrounding tumoral stroma 
rather than from the bone marrow [5-7,14]. 
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Conclusion 
In conclusion, present findings based on the GFP 
mouse bone marrow transplantation model, yielded 
in vivo evidence of BMDC involvement during cancer 
development and metastasis. Data on distinct 
distribution characteristics of GFP-positive BMDCs in 
primary and metastatic tumor microenvironment 
suggest that recruited BMDCs might be involved in 
cancer invasion and metastasis, while identification of 
GFP-positive macrophages, dendritic cells and 
circulating angioblasts attests to their multilineage 
potency and in turn the differential roles of these cells 
in tumor angiogenesis.  
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